Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zila Nutraceuticals

This article was originally published in The Tan Sheet

Executive Summary

Ronald Fugate named VP and general manager of Zila Nutraceuticals, Phoenix-based firm announces Sept. 18. Fugate brings experience from J&J, Kellogg Functional Foods Division to post; he most recently served as senior director-marketing at Bristol-Myers Squibb's Consumer Medicines division, where he led Pravachol Rx-to-OTC switch attempt (1"The Tan Sheet" July 24, 2000, p.12). In his new role, Fugate will look to introduce Zila's Ester-C vitamin C ingredient into new vitamin products. In a Sept. 18 conference call, Zila President & CEO Doug Burkett, PhD, said the firm expects to see 25% top line growth for Ester-C in 2002; ingredient recorded roughly $20 mil. in sales in 2001, firm says...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS094572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel